Phase II study of alternate-day treatment with S-1 as adjuvant chemotherapy for patients with lung cancer.
Phase of Trial: Phase II
Latest Information Update: 09 Apr 2019
Price : $35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Lung cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Mar 2019 Status changed from recruiting to completed.
- 12 Aug 2013 New trial record